9:45 AM
 | 
Jul 27, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Chinese xenotransplantation company Qihan grabs $7.8M series A

Hangzhou Qihan Bio Inc. (Hangzhou, China) raised $7.8 million on July 23 in a series A round led by Sequoia Capital China. Arch Venture Partners, Northern...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >